News & Announcements
Catalent to Acquire Paragon Bioservices for $1.2 Billion
April 15, 2019
Catalent Inc., a drug developer, announced that it plans to buy Paragon Bioservices, a UM BioPark anchor tenant, for $1.2 billion.
Read more in the following publications: